WealthTrust Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

WealthTrust Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-15,176	Closed	-$702K	–	84
2025 Q2	$702K	Buy	15,176 +527	+4%	+$25.9K	0.53%	48
2025 Q1	$893K	Buy	+14,649	New	+$854K	0.66%	33
2023 Q3	–	Sell	-13,239	Closed	-$847K	–	76
2023 Q2	$847K	Sell	13,239 -3,632	-22%	-$244K	0.77%	37
2023 Q1	$1.17M	Sell	16,871 -653	-4%	-$46.1K	1.11%	21
2022 Q4	$1.26M	Sell	17,524 -2,089	-11%	-$158K	1.22%	21
2022 Q3	$1.39M	Sell	19,613 -14,113	-42%	-$1.02M	1.47%	23
2022 Q2	$2.6M	Sell	33,726 -3,771	-10%	-$287K	2.45%	12
2022 Q1	$2.74M	Sell	37,497 -726	-2%	-$48.7K	1.95%	13
2021 Q4	$2.38M	Buy	38,223 +1,156	+3%	+$67.8K	1.59%	25
2021 Q3	$2.19M	Buy	37,067 +163	+0.4%	+$10.7K	1.95%	23
2021 Q2	$2.47M	Buy	+36,904	New	+$2.41M	2.14%	20

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

WealthTrust Asset Management's BMY Position: Q3 2025 in Review

WealthTrust Asset Management sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 15,176 shares — an estimated $702K sold.

WealthTrust Asset Management first reported a position in BMY in Q2 2021 and held it in 11 quarters. The position peaked at $2.74M in Q1 2022. 2,267 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

WealthTrust Asset Management reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
WealthTrust Asset Management sold 15,176 Bristol-Myers Squibb shares in Q3 2025, an estimated $702K.
WealthTrust Asset Management first reported a position in Bristol-Myers Squibb in Q2 2021 and held it in 11 quarters.
WealthTrust Asset Management's Bristol-Myers Squibb position peaked at $2.74M in Q1 2022.
2,267 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on WealthTrust Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.